Isabelle Naeije

Associate Global Trial Director at Novartis, Switzerland

Isabelle Naëije has a Master in Sciences degree in bio-engineering (Free University of Brussels, Belgium). She works for Novartis Pharma AG, Basel, Switzerland. She is an Assoc. Global Trial Director overseeing clinical trials (phase I to IV, oncology). She is currently assigned to two trials in radio ligand therapy (Glioblastoma and Small Cell Lung Cancer). In parallel, she is a patient engagement champion, bringing the voice of the patients at each step of the clinical development. She was part of the IMI PREFER workstream (Innovative medicine initiative, Patient Preferences in benefit risk assessments during the drug life cycle). Before taking this role at Novartis, she worked at Actelion Pharmaceuticals Ltd, Switzerland in the Clinical Pharmacology department. She came to Switzerland in 2011 after 5 years spent as Global Study Manager at Glaxo SmithKline Biologicals, Belgium. Prior to moving to the pharmaceutical industry, she worked as on-site clinical Research Assistant at the Erasmus University Hospital, Belgium. I